Mycobacterium abscessus complex: A Review of Recent Developments in an Emerging Pathogen

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Pulmonology

Background:

• The Mycobacterium abscessus complex (MABC) is a significant group of nontuberculous mycobacteria with increasing clinical relevance.
• Rising prevalence of MABC infections over the past two decades is noted, potentially linked to improved diagnostics and increased chronic lung disease.
• MABC infections are characterized by high rates of antimicrobial resistance and frequent patient relapses, leading to low cure rates.

Purpose of the Study:

• To review and integrate current knowledge on the epidemiology of MABC.
• To provide an overview of microbiological identification techniques for MABC.
• To familiarize readers with the molecular mechanisms of antimicrobial resistance and current therapeutic strategies for pulmonary MABC infections.

Main Methods:

• Literature review and synthesis of existing research on MABC.
• Analysis of epidemiological data and trends.
• Examination of microbiological and molecular identification methods.
• Review of studies on antimicrobial resistance mechanisms and treatment outcomes.

Main Results:

• MABC is a clinically important nontuberculous mycobacterium with increasing prevalence.
• Improved diagnostic techniques and higher rates of chronic lung disease contribute to observed MABC increases.
• Significant antimicrobial resistance and low cure rates are hallmarks of MABC pulmonary infections.
• Understanding resistance mechanisms is crucial for effective therapeutic strategies.

Conclusions:

• Pulmonary MABC infections pose a significant clinical challenge due to high resistance and low cure rates.
• Integrated knowledge of MABC epidemiology, diagnostics, resistance, and therapeutics is essential for improved patient outcomes.
• Further research into novel therapeutic approaches is warranted to combat MABC infections effectively.